FDA Initiates Coronavirus Medical Countermeasures
The U.S. Food and Drug Administration (FDA) is taking critical actions to advance development of novel coronavirus medical countermeasures.
NIAID Awards $30 Million to Develop Tuberculosis Vaccine
The awards establish and provide up to seven years of support for three Immune Mechanisms of Protection Against Mycobacterium Tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against Mtb infection.
NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
New Rabies Calculator Helps Providers Treat Patients Exposed to Rabies
Kedrion Biopharma has created the free, easy-to-use KEDRAB Dose Calculator to help healthcare providers treat rabies exposures.
Octapharma Introduces New SCIG Product and IgCares Program
Octapharma introduced its newest product, Cutaquig (immune globulin subcutaneous [human] 16.5% solution) at the Immune Deficiency Foundation (IDF) National Conference in June.
FDA Approves Octaplas to Treat Pediatric Patients Who Require Multiple Coagulation Factor Replacement
A revised product label for Octapharma USA’s Octaplas (pooled plasma [human] solvent/detergent treated solution for intravenous infusion) to treat critically ill pediatric patients who require replacement of multiple coagulation factors has been approved by the U.S. Food and Drug Administration (FDA).
HPV Vaccine Exceeds Expectations by Providing Herd Immunity
A new study shows the HPV vaccine is far more effective than expected, with benefits extending beyond those who receive the vaccine.
Researchers Discover New, Rare Autoimmune Disease
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis, Mo.
CMS Enacts Medicare, Medicaid and CHIP Fraud-Fighting Rules
A final rule that went into effect Nov. 4 strengthens the Centers for Medicare and Medicaid Services’ ability to stop fraud before it happens.
CMS Finalizes Rule for Programs of All-Inclusive Care for the Elderly
The Centers for Medicare and Medicaid Services (CMS) has finalized a rule to update and modernize the Programs of All-Inclusive Care for the Elderly (PACE) that reflects updates based upon best practices in caring for frail and elderly individuals.